Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RTNominal up3.020 +0.010 (+0.332%)
Result Announcements

29/08/2019 11:14

Sino Biopharm (01177) interim net up 6% to RMB1.44bn

[ET Net News Agency, 29 August 2019] Sino Biopharmaceutical Limited (01177) said its
profit attributable to owners of the parent was RMB1.44 billion for the six months ended
30 June 2019, a year-on-year increase of 5.76%. The earnings per share were RMB11.47
cents. The board of the company has declared the payment of a quarterly dividend of HK2
cents per share for the three months ended 30 June 2019. Together with the first quarterly
dividend of HK2 cents per share paid, the total dividend of first two quarters amounted to
HK4 cents per share.
The revenue was RMB12.53 billion, a year-on-year increase of 28.81%. The gross profit
was RMB10.08 billion, a year-on-year increase of 28.07%. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.